SPC510
Ozanimod eða lyfjafræðilega viðunandi salt þar af, að meðtöldu vetnisklóríðsaltinu / Ozanimod, or a pharmaceutically acceptable salt thereof, including the hydrochloride salt
Status:
UmsóknApplication date:
23.4.2025Application published:
1.5.2025
Medicine name:
ZeposiaMedicine for children:
No
Timeline
Today
23.4.2025Application
1.5.2025Publication
Marketing license
Foreign authorization number:
EU/1/20/1442Date:
20.5.2020
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP4098256